O preprint foi publicado em outro meio.
DOI do preprint publicado https://doi.org/10.1590/1677-5449.200057
Preprint / Versão 1

Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?

article.authors6a29ac77987da

  • Paulo Eduardo Ocke Reis Universidade Federal Fluminense – UFF, Departamento de Cirurgia Geral e Especializada, Niterói, RJ, Brasil https://orcid.org/0000-0001-5450-6806
    • Marcos Cesar Braga Lima Universidade Federal Fluminense – UFF, Departamento de Cirurgia Geral e Especializada, Niterói, RJ, Brasil

      Palavras-chave:

      COVID-19, coronavirus, anticoagulants, thrombosis, prevention, hospital mortality

      Resumo

      Many patients with COVID-19 have thromboembolic complications that worsen their prognosis. Herein, the authors propose a modified version of the CHA2DS2-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the condition becomes severe. The advantages of this modification would be prevention of the patient’s condition worsening due to thromboembolic problems and reduction of the likelihood of a need for intensive care and mechanical ventilation, reducing mortality.

      Downloads

      Os dados de download ainda não estão disponíveis.

      Postado

      18/05/2020

      Como Citar

      Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?. (2020). Em SciELO Preprints. https://preprints.scielo.org/index.php/scielo/preprint/view/518

      Série

      Ciências da Saúde

      Copyright (c) 2020 Paulo Eduardo Ocke Reis, Marcos Cesar Braga Lima

      Creative Commons License
      Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.

      Plaudit